<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02548884</url>
  </required_header>
  <id_info>
    <org_study_id>Difficult cannulation</org_study_id>
    <nct_id>NCT02548884</nct_id>
  </id_info>
  <brief_title>Pancreatic Sphincterotomy Versus Double Wire Technique in Difficult Cannulation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare two different techniques (pancreatic sphincterotomy&#xD;
      (PS) and double wire technique (DGW)) regarding the risk of post-ERCP pancreatitis (PEP) and&#xD;
      the success of cannulation in difficult cannulation. For the study, the difficult cannulation&#xD;
      is de-fined as situation when the common bile duct has not been cannulated in five minutes,&#xD;
      after five attempts or after two pancreatic guide wire passages or when any of those limits&#xD;
      is exceeded. The two techniques, the PS and the DGW, will be compared in random fashion. The&#xD;
      primary end-point is the risk of PEP .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post ERCP pancreatitis defined by ESGE guidelines published 2014</measure>
    <time_frame>48 hours</time_frame>
    <description>Acute pancreatitis within 48 hours post ERCP. Post-ERCP pancreatitis (PEP) is defined as the presence of abdominal pain attributable to acute pancreatitis, together with a need for an unplanned hospitalization or an extension of a planned hospitalization by at least 2 days, and a serum /plasma amylase at least 3 times above the upper limit of normal at 24 hours after the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biliary cannulation success within 15 minutes after randomization</measure>
    <time_frame>15 minutes</time_frame>
    <description>After randomization, timing to get the wire in biliary duct. First assessed the number of procedures succeeded in 15 minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biliary cannulation success, total number</measure>
    <time_frame>2 hours</time_frame>
    <description>The total number of successful biliary cannulations after randomization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1190</enrollment>
  <condition>Endoscopic Retrograde Cholangiopancreatography</condition>
  <arm_group>
    <arm_group_label>Pancreatic sphincterotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pancreatic sphincterotomy technique used in difficult biliary cannulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double guide wire</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Double guide wire technique used in difficult biliary cannulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biliary cannulation</intervention_name>
    <arm_group_label>Double guide wire</arm_group_label>
    <arm_group_label>Pancreatic sphincterotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Naive papilla, ERCP indication common bile duct cannulation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No consent to the study&#xD;
&#xD;
          -  Ongoing pancreatitis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Halttunen J, Meisner S, Aabakken L, Arnelo U, Grönroos J, Hauge T, Kleveland PM, Nordblad Schmidt P, Saarela A, Swahn F, Toth E, Mustonen H, Löhr JM. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. 2014 Jun;49(6):752-8. doi: 10.3109/00365521.2014.894120. Epub 2014 Mar 14.</citation>
    <PMID>24628493</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 3, 2015</study_first_submitted>
  <study_first_submitted_qc>September 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2015</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Leena Kylanpaa</investigator_full_name>
    <investigator_title>M.D, Ph.D</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

